LB5. PROVENT: Phase 3 Study of Efficacy and Safety of AZD7442 (Tixagevimab/Cilgavimab) for Pre-expos...
LB5. PROVENT: Phase 3 Study of Efficacy and Safety of AZD7442 (Tixagevimab/Cilgavimab) for Pre-exposure Prophylaxis of COVID-19 in Adults
About this item
Full title
Author / Creator
Levin, Myron J , Ustianowski, Andrew , De Wit, Stéphane , Launay, Odile , Avila, Miles , Seegobin, Seth , Templeton, Alison , Yuan, Yuan , Ambery, Philip , Arends, Rosalinda H , Beavon, Rohini , Near, Karen A , Padilla, Kelly W , Psachoulia, Konstantina , Sharbaugh, Audrey , Streicher, Katie , Pangalos, Menelas N , Esser, Mark T and Gasser, Robert A
Publisher
US: Oxford University Press
Journal title
Language
English
Formats
Publication information
Publisher
US: Oxford University Press
Subjects
More information
Alternative Titles
Full title
LB5. PROVENT: Phase 3 Study of Efficacy and Safety of AZD7442 (Tixagevimab/Cilgavimab) for Pre-exposure Prophylaxis of COVID-19 in Adults
Authors, Artists and Contributors
Author / Creator
Ustianowski, Andrew
De Wit, Stéphane
Launay, Odile
Avila, Miles
Seegobin, Seth
Templeton, Alison
Yuan, Yuan
Ambery, Philip
Arends, Rosalinda H
Beavon, Rohini
Near, Karen A
Padilla, Kelly W
Psachoulia, Konstantina
Sharbaugh, Audrey
Streicher, Katie
Pangalos, Menelas N
Esser, Mark T
Gasser, Robert A
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8644063
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8644063
Other Identifiers
ISSN
2328-8957
E-ISSN
2328-8957
DOI
10.1093/ofid/ofab466.1646
